ACRES Commercial Realty (ACR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 5, 2025, to elect nine directors, approve executive compensation (Say on Pay), and ratify Ernst & Young LLP as the independent auditor for 2025.
Proxy materials are provided via Internet to conserve resources, with multiple voting methods available for shareholders.
Only shareholders of record as of April 9, 2025, are entitled to vote; approximately 7.4 million shares outstanding.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of nine directors, (2) non-binding Say on Pay for executive compensation, (3) ratification of Ernst & Young LLP as auditor.
Proposals 1 and 2 are non-routine and require direct shareholder voting; Proposal 3 is routine and can be voted by brokers.
Shareholders can submit proposals or director nominations for the 2026 meeting by December 12, 2025, following specific bylaw requirements.
Board of directors and corporate governance
Board consists of nine nominees, with six deemed independent under NYSE rules.
Four standing committees: Audit, Compensation, Nominating/ESG, and Investment; all but Investment Committee are composed solely of independent directors.
Board conducts annual self-assessments and emphasizes diversity, inclusion, and ongoing director education.
Stockholders have the right to amend bylaws and communicate directly with the Board.
Board leadership is separated between Chairman and CEO roles.
Latest events from ACRES Commercial Realty
- $571M in new loans, $3M net loss, book value up to $30.01, and $1B CRE CLO closed.ACR
Q4 20255 Mar 2026 - Net income and book value rose, with 79% of loans in multifamily and strong liquidity.ACR
Q2 20242 Feb 2026 - Q3 2024 net income rose to $2.8M, book value per share hit $27.92, and liquidity stayed strong.ACR
Q3 202417 Jan 2026 - Q1 net loss, portfolio contraction, and new $939.9M facility amid elevated credit risk.ACR
Q1 202524 Dec 2025 - Book value and EAD rose on asset sales; strong multifamily loans and portfolio growth expected.ACR
Q4 202424 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.ACR
Proxy Filing1 Dec 2025 - Q2 2025 saw a net loss, $27.93 book value per share, and a $1.4B CRE loan portfolio.ACR
Q2 202516 Nov 2025 - Q3 net income was $9.8M ($1.34/share), book value rose, and portfolio growth is expected.ACR
Q3 20256 Nov 2025